The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...
Topol pioneered the development of many routinely used medications, including tissue plasminogen activator, clopidogrel (Plavix), bivalirudin (Angiomax), and abciximab (ReoPro), and was the first ...
Heparin sodium 1000, 5000, 10000units; per mL; IV or SC inj; preservative-free or preserved with benzyl alcohol. History of heparin-induced thrombocytopenia (HIT) or heparin-induced ...
All three approved products are Fab molecules. ReoPro (abciximab; Centocor) targets platelet glycoprotein (GP) IIb/IIIa and was approved by the FDA in December 1994 (refs. 36,37). The product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback